home / stock / bvaxf / bvaxf quote
Last: | $0.05 |
---|---|
Change Percent: | -0.1% |
Open: | $0.05 |
Close: | $0.05 |
High: | $0.05 |
Low: | $0.04 |
Volume: | 12,959 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.05 | $0.05 | $0.05 | $0.05 | $0.04 | 12,959 | 07-05-2024 |
$0.05 | $0.04415 | $0.04995 | $0.05 | $0.0442 | 21,113 | 07-04-2024 |
$0.04995 | $0.04415 | $0.04995 | $0.04995 | $0.04415 | 21,113 | 07-03-2024 |
$0.0499 | $0.04 | $0.0499 | $0.0499 | $0.04 | 224,407 | 07-02-2024 |
$0.05 | $0.0499 | $0.05 | $0.05 | $0.04 | 85,098 | 07-01-2024 |
$0.0499 | $0.0499 | $0.0499 | $0.0499 | $0.04 | 10,750 | 06-28-2024 |
$0.05 | $0 | $0.05 | $0 | $0 | 98 | 06-27-2024 |
$0.05 | $0.04005 | $0.05 | $0.05 | $0.0301 | 67,041 | 06-25-2024 |
$0.0487 | $0.04195 | $0.0487 | $0.0487 | $0.04195 | 9,650 | 06-24-2024 |
$0.05 | $0 | $0.05 | $0 | $0 | 102 | 06-21-2024 |
$0.05 | $0.0444 | $0.05 | $0.05 | $0.0444 | 7,641 | 06-20-2024 |
$0.049 | $0.05 | $0.049 | $0.05 | $0.0419 | 93,002 | 06-19-2024 |
$0.049 | $0.05 | $0.049 | $0.05 | $0.04185 | 93,002 | 06-18-2024 |
$0.0505 | $0.0501 | $0.0505 | $0.0515 | $0.0387 | 188,621 | 06-17-2024 |
$0.051 | $0.0515 | $0.051 | $0.0515 | $0.051 | 143,973 | 06-14-2024 |
$0.0515 | $0.0515 | $0.0515 | $0.052 | $0.0514 | 37,025 | 06-13-2024 |
$0.052 | $0.0515 | $0.052 | $0.052 | $0.0515 | 2,130 | 06-12-2024 |
$0.0518 | $0.052 | $0.0518 | $0.053 | $0.051 | 44,810 | 06-11-2024 |
$0.0531 | $0.0531 | $0.0531 | $0.0531 | $0.0531 | 1,000 | 06-10-2024 |
$0.052 | $0.052 | $0.052 | $0.052 | $0.052 | 37,921 | 06-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order Canada NewsWire VANCOUVER, BC , May 16, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (the...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Canada NewsWire USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC , May 1, 2024 /CNW/ -- USA News Group ...
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER Canada NewsWire VANCOUVER, BC , April 30, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") is pleased to announce that it has appointed Chris...